Diacerein: Advantages and disadvantages

<p align="LEFT">Diacerein (DR) is a medication from a group of symptomatic slow-acting agents (chondroprotectors), which has an original mechanism of action and is widely used in Russia and many countries in the world to treat osteoarthrosis (OA). The ability of DR to affect its majo...

Full description

Bibliographic Details
Main Author: Andrei Evgenyevich Karateev
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2014-12-01
Series:Современная ревматология
Subjects:
Online Access:http://mrj.ima-press.net/index.php/mrj/article/view/581
_version_ 1819027391031279616
author Andrei Evgenyevich Karateev
author_facet Andrei Evgenyevich Karateev
author_sort Andrei Evgenyevich Karateev
collection DOAJ
description <p align="LEFT">Diacerein (DR) is a medication from a group of symptomatic slow-acting agents (chondroprotectors), which has an original mechanism of action and is widely used in Russia and many countries in the world to treat osteoarthrosis (OA). The ability of DR to affect its major symptoms and progression has been shown in a series of well-organized clinical trials. However, the supervisory health bodies of the European Union have presently made a decision to restrict the use of DR, which is associated with the fact that the viewpoint of this drug's safety level has been changed. The case in point is gastrointestinal complications (diarrhea) and hepatotoxic reactions, which may be caused by DR treatment. This review considers the results of the most known clinical trials of DR, gives basic data on its adverse reactions, and assesses prospects for using its new generic drugs.</p><em></em>
first_indexed 2024-12-21T05:41:43Z
format Article
id doaj.art-644f13935a4245378380eb42cdee548b
institution Directory Open Access Journal
issn 1996-7012
2310-158X
language Russian
last_indexed 2024-12-21T05:41:43Z
publishDate 2014-12-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj.art-644f13935a4245378380eb42cdee548b2022-12-21T19:14:15ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2014-12-010490951882Diacerein: Advantages and disadvantagesAndrei Evgenyevich Karateev0V.A. Nasonova Research Institute of Rheumatology<p align="LEFT">Diacerein (DR) is a medication from a group of symptomatic slow-acting agents (chondroprotectors), which has an original mechanism of action and is widely used in Russia and many countries in the world to treat osteoarthrosis (OA). The ability of DR to affect its major symptoms and progression has been shown in a series of well-organized clinical trials. However, the supervisory health bodies of the European Union have presently made a decision to restrict the use of DR, which is associated with the fact that the viewpoint of this drug's safety level has been changed. The case in point is gastrointestinal complications (diarrhea) and hepatotoxic reactions, which may be caused by DR treatment. This review considers the results of the most known clinical trials of DR, gives basic data on its adverse reactions, and assesses prospects for using its new generic drugs.</p><em></em>http://mrj.ima-press.net/index.php/mrj/article/view/581diacereinefficacyadverse reactionsdiarrheahepatotoxic reactions
spellingShingle Andrei Evgenyevich Karateev
Diacerein: Advantages and disadvantages
Современная ревматология
diacerein
efficacy
adverse reactions
diarrhea
hepatotoxic reactions
title Diacerein: Advantages and disadvantages
title_full Diacerein: Advantages and disadvantages
title_fullStr Diacerein: Advantages and disadvantages
title_full_unstemmed Diacerein: Advantages and disadvantages
title_short Diacerein: Advantages and disadvantages
title_sort diacerein advantages and disadvantages
topic diacerein
efficacy
adverse reactions
diarrhea
hepatotoxic reactions
url http://mrj.ima-press.net/index.php/mrj/article/view/581
work_keys_str_mv AT andreievgenyevichkarateev diacereinadvantagesanddisadvantages